Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial | Breast Cancer | JAMA
This randomized trial assesses whether metformin (vs placebo) given for 5 years would improve invasive disease–free survival and other outcomes in patients with
Source: jamanetwork.com